Nformbuh Asangmbeng, MD
Internal Medicine · Macon, GANPI 1740786573
Payments from drug & device makers
Across 51 payments — averaging $78.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$1K
- Abbott$379
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$297
- Cvrx, Inc.$231
- Pfizer$218
- Johnson & Johnson$217
- plus $2K from 18 others
What the payments were for
- Travel & lodging$95224%
- Food & beverage$2,75069%
- Education$2997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 7 | $1,148 |
| Abbott | 3 | $379 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $297 |
| Cvrx, Inc. | 1 | $231 |
| Pfizer | 3 | $218 |
| Johnson & Johnson | 5 | $217 |
| Recor Medical Inc | 2 | $167 |
| Boston Scientific | 1 | $160 |
| E.r. Squibb & Sons, L.L.C. | 5 | $143 |
| Penumbra, Inc. | 1 | $141 |
| AstraZeneca(2 entities) | 2 | $140 |
| Scpharmaceuticals Inc. | 1 | $124 |
| Heartflow, Inc. | 1 | $119 |
| Novo Nordisk | 1 | $117 |
| Kestra Medical Technology Services, Inc. | 2 | $89 |
| Chiesi USA, Inc. | 1 | $70 |
| Medtronic(2 entities) | 2 | $69 |
| Novartis | 3 | $59 |
| Merck | 1 | $23 |
| Gilead | 1 | $23 |
| Mylan Specialty L.p. | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$1,017
- ELIQUIS$259
- Barostim Neo System$231
- EnSite Precision Cardiac Mapping System$212
- LifeVest$141
- Indigo System$141
- PARADISE RENAL DENERVATION SYSTEM$125
- LOKELMA$125
- FUROSCIX$124
- FFRct$119
- XIENCE SKYPOINT$116
How this compares
$4,001 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 26 | $150 |
| Atorvastatin Calcium | 15 | $92 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Macon
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
- Charles KempAlbany$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.